Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Phages and cancer immunity Gut bacteria are involved in the education of T cell immune responses, and the intestinal ecosystem influences anticancer immunity. Fluckiger et al. report microbial antigens that might cross-react with antigens associated with tumor cells. They found that a type of intestinal bacteria called enterococci harbor a bacteriophage that modulates immune responses. In mouse models, administration of enterococci containing the bacteriophage boosted T cell responses after treatment with chemotherapy or programmed cell death protein 1 (PD-1) blockade. In humans, the presence of the bacteriophage was associated with improved survival after PD-1 immunotherapy. A fraction of human T cells specific for naturally processed melanoma epitopes appeared to be able to recognize microbial peptides. This “molecular mimicry” may represent cross-reactivity between tumors and microbial antigens. Science , this issue p. 936
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, bacteriophages as therapeutic strategies could modulate the gut microbiota, immunity, and TME [70, 164–166].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“an E. hirae strain carrying a prophage from the Siphoviridae family translocates to mLNs and the spleen”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“boosts the T cell-dependent efficacy of cyclophosphamide or PD-1 blockade”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“molecular mimicry between microbial and tumor-associated antigens, resulting in cross-reactive T cell responses 55”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, the gut microbiome’s vast antigen reservoir may facilitate cross-reactivity between bacterial and tumor antigens, thereby enhancing antitumor immune responses (Fluckiger et al., 2020; Naghavian et al., 2023).”
From Microbiota-centered interventions to boost immune checkpoint blockade therapies (2025) · cites this paper as Fluckiger et al., 2020
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Guindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
OrthoMCL: Identification of Ortholog Groups for Eukaryotic Genomes
Li, L., Stoeckert, C. J., & Roos, D. S. (2003) · Genome Research · doi:10.1101/gr.1224503 · Cited by 5,707
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Self-citationAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Self-citationImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Cited by
Items 101–200 of 402
Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases
Haddad, L. E., Mendoza, J. F., & Jobin, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1055427 · Cited by 45
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Feola, S., Chiaro, J., Martins, B., Russo, S., Fusciello, M., Ylösmäki, E. O., Bonini, C., Ruggiero, E., Hamdan, F., Feodoroff, M., et al. (2022) · eLife · doi:10.7554/elife.71156 · Cited by 47
Bacteriophage-mediated modulation of microbiota for diseases treatment
Zhang, Y., Li, C., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113856 · Cited by 46
Endotoxin-Free Outer Membrane Vesicles for Safe and Modular Anticancer Immunotherapy
Chen, M.-Y., Cheng, T.-W., Pan, Y., Mou, C., Chiang, Y., Lin, W., Hu, C. J., & Mou, Y. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00483 · Cited by 43
Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer
Wang, N., Sun, T., & Xu, J. (2021) · Journal of Cancer · doi:10.7150/jca.58986 · Cited by 42
Non-mutational neoantigens in disease
Stern, L. J., Clement, C. C., Galluzzi, L., & Santambrogio, L. (2024) · Nature Immunology · doi:10.1038/s41590-023-01664-1 · Cited by 46
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Davar, D., & Zarour, H. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1129 · Cited by 40
“hirae bacteriophage elicited commensal-specific T cells that cross-reacted with candidate neoantigens (19, 68).”
BackgroundCross-reactivity between microbial and tumor antigens
Zitvogel, L., & Kroemer, G. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102171 · Cited by 40
Self-citationPovlsen, H. R., Bentzen, A. K., Kadivar, M., Jessen, L. E., Hadrup, S. R., & Nielsen, M. (2023) · eLife · doi:10.7554/elife.81810 · Cited by 42
Regulation of tissue-resident memory T cells by the Microbiota
Overacre-Delgoffe, A. E., & Hand, T. W. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00491-1 · Cited by 41
Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy
Bolte, L. A., Björk, J. R., Gaćeša, R., & Weersma, R. K. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.04.025 · Cited by 41
Influence of immunomodulatory drugs on the gut microbiota
Cohen, I., Ruff, W. E., & Longbrake, E. E. (2021) · Translational research · doi:10.1016/j.trsl.2021.01.009 · Cited by 39
Patient-derived cancer models: Valuable platforms for anticancer drug testing
Genta, S., Coburn, B. A., Cescon, D. W., & Spreafico, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.976065 · Cited by 40
Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer
Montégut, L., de Cabo, R., Zitvogel, L., & Kroemer, G. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0504 · Cited by 38
Self-citationWang, W., Lu, G., Wu, X., Wen, Q., & Zhang, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030780 · Cited by 38
Microbiota-induced T cell plasticity enables immune-mediated tumour control
Najar, T. A., Hao, Y., Hao, Y., Romero‐Meza, G., Dolynuk, A., Almo, E., & Littman, D. R. (2026) · Nature · doi:10.1038/s41586-025-09913-z · Cited by 39
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
Kouidhi, S., Zidi, O., Belkhiria, Z., Raïs, H., Ayadi, A., Ayed, F. B., Mosbah, A., Cherif, A., & Gaaied, A. B. A. E. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00132 · Cited by 39
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification
Feola, S., Haapala, M., Peltonen, K., Capasso, C., Martins, B., Antignani, G., Federico, A., Pietiäinen, V., Chiaro, J., Feodoroff, M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c04371 · Cited by 36
Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy
Javaudin, F., Latour, C., Debarbieux, L., & Lamy-Besnier, Q. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00136-21 · Cited by 39
Self-citationGut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Wang, J., Zhu, N., Su, L., & Yang, R. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216582 · Cited by 37
Somodi, C., Dóra, D., Horváth, M., Szegvári, G., & Lohinai, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06586-0 · Cited by 40
Therapeutic potential of microbial modulation in pancreatic cancer
Chandra, V., & McAllister, F. M. (2021) · Gut · doi:10.1136/gutjnl-2019-319807 · Cited by 37
Microbiome influencers of checkpoint blockade–associated toxicity
Wang, Y., Jenq, R. R., Wargo, J. A., & Watowich, S. S. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220948 · Cited by 37
Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 37
Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer
Lee, W. S., Lee, S. J., Lee, H. J., Yang, H., Go, E., Enkhtaivan, G., Song, K., Xiang, X., Park, D.-G., Alain, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53347-6 · Cited by 36
Immune–bacteriophage interactions in inflammatory bowel diseases
Gogokhia, L., & Round, J. L. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.04.010 · Cited by 34
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33
“MIDS also includes mimicry between microbial and cancer antigens.[156,157] Should genetic cargo be shared between intracellular bacteria and host cells, as biotechnology already shows is possible[24] and cancer virology affirms,[45,46] MIDS must account for DNA and”
BackgroundInfluence of Microbiota on Tumor Immunotherapy
Yu, X., Li, W., Li, Z., Wu, Q., & Sun, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91771 · Cited by 37
Translating Microbiome Research From and To the Clinic
Zhang, Z. J., Lehmann, C. J., Cole, C. G., & Pamer, E. G. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-022206 · Cited by 33
Xin, Y., Liu, C., Zang, D., & Chen, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343450 · Cited by 39
Regulation of T cell repertoires by commensal microbiota
Kim, K. S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1004339 · Cited by 36
Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
Zhang, H., & Xu, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1257515 · Cited by 33
HLA-A29 and Birdshot Uveitis: Further Down the Rabbit Hole
Kuiper, J. J. W., & Venema, W. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599558 · Cited by 32
Redrawing therapeutic boundaries: microbiota and cancer
Sholl, J., Sepich‐Poore, G. D., Knight, R. D., & Pradeu, T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.008 · Cited by 33
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
Modica, M. D., Arlotta, V., Sfondrini, L., Tagliabue, E., & Triulzi, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947188 · Cited by 36
Tumor-resident microbes: the new kids on the microenvironment block
Li, L., Chandra, V., & McAllister, F. (2024) · Trends in Cancer · doi:10.1016/j.trecan.2023.12.002 · Cited by 30
Farfán, J., González, J. M., & Vives, M. J. (2022) · PeerJ · doi:10.7717/peerj.13553 · Cited by 35
Haberman, Y., Kamer, I., Amir, A., Goldenberg, S., Efroni, G., Daniel‐Meshulam, I., Lobachov, A., Daher, S., Hadar, R., Gantz-Sorotsky, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29136-4 · Cited by 33
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Araujo, D. V., Watson, G. A., Oliva, M., Heirali, A., Coburn, B., Spreafico, A., & Siu, L. L. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102125 · Cited by 29
A Mammalian Cell's Guide on How to Process a Bacteriophage
Kan, L., & Barr, J. J. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-111322 · Cited by 30
The Roles of the Virome in Cancer
Broecker, F., & Moelling, K. (2021) · Microorganisms · doi:10.3390/microorganisms9122538 · Cited by 34
The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
Qi, X., Liu, Y., Hussein, S., Choi, G., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2022) · Cells · doi:10.3390/cells11223684 · Cited by 30
Duttagupta, S., Hakozaki, T., Routy, B., & Messaoudene, M. (2023) · Current Oncology · doi:10.3390/curroncol30110681 · Cited by 31
Self-citationWu, H., Deng, M., Xue, D., Guo, R., Zhang, C., Gao, J., & Li, H. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04654-3 · Cited by 30
Wang, L., Jiang, W., Yang, M., Danzeng, Q., Liu, S., & Cui, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02275-z · Cited by 29
Inosine: novel microbiota-derived immunostimulatory metabolite
Kroemer, G., & Zitvogel, L. (2020) · Cell Research · doi:10.1038/s41422-020-00417-1 · Cited by 28
Self-citationCancer and immunotherapy: a role for microbiota composition
Pham, F., Moinard‐Butot, F., Coutzac, C., & Chaput, N. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.06.051 · Cited by 29
Poizeau, F., Kerbrat, S., Balusson, F., Tattevin, P., Revest, M., Cattoir, V., Paz, D. L., Lesimple, T., Pracht, M., Dinulescu, M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac019 · Cited by 28
Self-citationMicrobial mechanisms to improve immune checkpoint blockade responsiveness
Griffin, M. E., & Hang, H. C. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100818 · Cited by 31
Bredin, P., & Naidoo, J. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10039-1 · Cited by 29
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
Zhang, H., Hong, Y., Wu, T., Ben, E., Li, S., Hu, L., & Xie, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401967 · Cited by 27
Intratumoral bacteria generate a new class of therapeutically relevant tumor antigens in melanoma
Sepich‐Poore, G. D., Carter, H. K., & Knight, R. D. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.008 · Cited by 30
Antigen transfer and its effect on vaccine-induced immune amplification and tolerance
Shi, Y., Lu, Y., & You, J. (2022) · Theranostics · doi:10.7150/thno.75904 · Cited by 28
Yang, S., Zhao, S., Ye, Y., Jia, L., & Lou, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952546 · Cited by 32
Feng, Z., Burgermeister, E., Philips, A., Zuo, T., & Wen, W. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf010 · Cited by 26
Influence of the microbiome on solid organ transplant survival
Pirozzolo, I., Li, Z., Sepulveda, M., & Alegre, M. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.004 · Cited by 27
The microbiome, gastrointestinal cancer, and immunotherapy
Newsome, R. C., Yang, Y., & Jobin, C. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15742 · Cited by 28
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives
Li, D., Wu, R., Yu, Q., Tuo, Z., Wang, J., Yoo, K. H., Wei, W., Yang, Y., Ye, L., Guo, Y., et al. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.03 · Cited by 30
New insights into gut microbiota–prostate cancer crosstalk
Laaraj, J., Lachance, G., Bergeron, A., Fradet, Y., Robitaille, K., & Fradet, V. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.03.015 · Cited by 27
Cancer microbiota: a focus on tumor-resident bacteria
Vella, G., & Rescigno, M. (2025) · EMBO Reports · doi:10.1038/s44319-025-00482-w · Cited by 26
Nobre, J. G., & Costa, D. A. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1020190 · Cited by 26
Gouttefangeas, C., Klein, R., & Maia, A. R. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212546 · Cited by 25
Wang, W., Fan, J., Zhang, C., Huang, Y., Chen, Y., Fu, S., & Wu, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127668 · Cited by 25
Cross-reactivity between cancer and microbial antigens
Zitvogel, L., & Kroemer, G. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1877416 · Cited by 25
Self-citationIleal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
Picard, M., Yonekura, S., Slowicka, K., Petta, I., Rauber, C., Routy, B., Richard, C., Iebba, V., Tidjani Alou, M., Becharef, S., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00684-w · Cited by 24
Self-citationZorea, J., Motro, Y., Mazor, R. D., Carmi, Y. K., Shulman, Z., Mahajna, J. A., Moran‐Gilad, J., & Elkabets, M. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02680-7 · Cited by 36
Tomasi, M., Caproni, E., Benedet, M., Zanella, I., Giorgetta, S., Dalsass, M., König, E., Gagliardi, A., Fantappiè, L., Berti, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.912639 · Cited by 25
Self-citationWang, S., Xu, B., Zhang, Y., Chen, G., Zhao, P., Gao, Q., & Yuan, L. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0376 · Cited by 32
Impact of the ONCOBIOME network in cancer microbiome research
Zitvogel, L., Derosa, L., Routy, B., Loibl, S., Heinzerling, L., de Vries, I. J. M., Engstrand, L., ONCOBIOME Network, Silva, C. A. C., Barbieri, D., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03608-8 · Cited by 23
Self-citationChen, L., Li, B., Zu, M., Reis, R. L., Kundu, S. C., & Xiao, B. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.012 · Cited by 24
Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response
Sfanos, K. S. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1857 · Cited by 23
Gut Microbiota–Related Biomarkers in Immuno-Oncology
Silva, C. A. C., Fidelle, M., Almonte, A. A., Derosa, L., & Zitvogel, L. (2025) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061124-102218 · Cited by 22
Self-citationXu, K., Motiwala, Z. Y., Corona‐Avila, I., Makhanasa, D., Alkahalifeh, L., & Khan, M. W. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338251331960 · Cited by 25
The cure from within? a review of the microbiome and diet in melanoma
Kumar, P. R., Brazel, D., DeRogatis, J. M., Goldstein, J. B., Whiteson, K., Chow, W. A., Tinoco, R., & Moyers, J. T. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10029-3 · Cited by 25
Social Isolation and Breast Cancer
Hilakivi-Clarke, L. A., & Andrade, F. D. O. (2023) · Endocrinology · doi:10.1210/endocr/bqad126 · Cited by 23
Stem‐like T cells in cancer and autoimmunity
Schnell, A. (2024) · Immunological Reviews · doi:10.1111/imr.13356 · Cited by 22
Hao, Q., Long, Y., Yang, Y., Deng, Y., Ding, Z., Yang, L., Shu, Y., & Xu, H. (2024) · Vaccines · doi:10.3390/vaccines12070717 · Cited by 27
The gut microbiome modulate response to immunotherapy in cancer
Jiang, S., Kang, Z., Chen, Y., & Fang, J. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2634-7 · Cited by 22
Berbers, R.-M., Paganelli, F. L., van Montfrans, J. M., Ellerbroek, P. M., Viveen, M. C., Rogers, M. R. C., Salomons, M., Schuurmans, J., Thans, M. V. S., Vanmaris, R. M. M., et al. (2025) · Microbiome · doi:10.1186/s40168-024-01982-y · Cited by 20
Modeel, S., Siwach, S., Dolkar, P., Chaurasia, M., Yadav, P., Atri, A., Yadav, A., Negi, T., & Negi, R. K. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.06.007 · Cited by 25
Fecal Microbiota Transplantation as a Cancer Therapeutic
Stoff, R., Wolf, Y., & Boursi, B. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000651 · Cited by 23
Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota
Wen, M., Li, Y., Qin, X., Qin, B., & Wang, Q. A. (2023) · Cells · doi:10.3390/cells12141882 · Cited by 21
Microbiota: A key factor affecting and regulating the efficacy of immunotherapy
Jiang, Y., Jia, D., Sun, Y., Ding, N., & Wang, L. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1508 · Cited by 22
The human microbiome: redefining cancer pathogenesis and therapy
Adlakha, Y. K., & Chhabra, R. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03787-x · Cited by 25
The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
Deluce, J. E., Vareki, S. M., & Fernandes, R. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221122714 · Cited by 22
Microbiota-centered interventions to boost immune checkpoint blockade therapies
Almonte, A. A., Thomas, S., & Zitvogel, L. (2025) · Journal of Experimental Medicine · doi:10.1084/jem.20250378 · Cited by 19
Self-citationSusiriwatananont, T., Eiamprapaporn, P., Roque, M. V., Farraye, F. A., Pearlman, A., & Chumsri, S. (2025) · Cells · doi:10.3390/cells14221779 · Cited by 21
Dravillas, C. E., Coleman, S. S., Hoyd, R., Caryotakis, G., Denko, L., Chan, C. H. F., Churchman, M. L., Denko, N. C., Dodd, R. D., Eljilany, I., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0170 · Cited by 21
Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance
Liu, Y., Zhou, J., Yang, Y., Chen, X., Chen, L., & Wu, Y. (2024) · Vaccines · doi:10.3390/vaccines12080868 · Cited by 20
Zheng, J., & Chen, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1429722 · Cited by 20
Spiliopoulou, P., Vornicova, O., Genta, S., & Spreafico, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021294 · Cited by 20
The microbiota in radiotherapy-induced cancer immunosurveillance
Chen, J., Deutsch, É., Kroemer, G., Galluzzi, L., & Zitvogel, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01052-8 · Cited by 19
Self-citationThe mechanisms and therapeutic potential of the microbiome-immune interface in cancer
Christina, B., Poongkuzhali, S., Muninathan, N., Bhaskaran, K., & Suresh, A. (2025) · Discover Biotechnology · doi:10.1007/s44340-025-00031-0 · Cited by 18
Integrating immunopeptidome analysis for the design and development of cancer vaccines
Feola, S., Chiaro, J., & Cerullo, V. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101750 · Cited by 19
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
Tomasi, M., Dalsass, M., Beghini, F., Zanella, I., Caproni, E., Fantappiè, L., Gagliardi, A., Irene, C., König, E., Frattini, L. F., et al. (2021) · Vaccines · doi:10.3390/vaccines9111356 · Cited by 21
Self-citationBaaziz, H., Baker, Z. R., Franklin, H. C., & Hsu, B. B. (2022) · iScience · doi:10.1016/j.isci.2022.104146 · Cited by 19
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors
Gunjur, A., Manrique-Rincón, A., Klein, O., Behren, A., Lawley, T. D., Welsh, S. J., & Adams, D. J. (2022) · The Journal of Pathology · doi:10.1002/path.5907 · Cited by 20
Engineered bacteria potentiate cancer immunotherapy
Sun, M., Yang, J.-Z., Li, L., Li, Y., Li, W., & Ding, J. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111093 · Cited by 18
Mattiola, I., & Diefenbach, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101724 · Cited by 19
Han, W., Wang, N., Han, M., Liu, X., Sun, T., & Xu, J. (2023) · Cancer Medicine · doi:10.1002/cam4.6503 · Cited by 19
Metadata
- Authors
- Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., Lemaitre, F., Ferrere, G., Derosa, L., Duong, C. P. M., Messaoudene, M., Gagné, A., Joubert, P., De Sordi, L., Debarbieux, L., Simon, S., Scarlata, C.-M., Ayyoub, M., Palermo, B., Facciolo, F., Boidot, R., Wheeler, R., Boneca, I. G., Sztupinszki, Z., Papp, K., Csabai, I., Pasolli, E., Segata, N., Lopez-Otin, C., Szallasi, Z., Andre, F., Iebba, V., Quiniou, V., Klatzmann, D., Boukhalil, J., Khelaifia, S., Raoult, D., Albiges, L., Escudier, B., Eggermont, A., Mami-Chouaib, F., Nistico, P., Ghiringhelli, F., Routy, B., Labarrière, N., Cattoir, V., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Université de Bourgogne (FR)
- Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Bacteriophage, Bacterium, Host Laboratory, Institut Pasteur, F-75015 Paris, France.
- Institut Pasteur (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Instituto Nazionale Tumori Regina Elena (IT)
- Centre Georges François Leclerc (FR)
- Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.
- Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
- University of Naples Federico II (IT)
- University of Trento (IT)
- Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
- Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France.
- University of Trieste (IT)
- UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.
- Aix-Marseille Université (FR)
- Institut Gustave Roussy (FR)
- INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France.
- Unit of Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
- Karolinska University Hospital (SE)
- Corresponding author
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fluckiger, Aurélie
- Daillère, Romain
- Sassi, Mohamed
- Sixt, Barbara Susanne
- Liu, Peng
- Loos, Friedemann
- Richard, Corentin
- Rabu, Catherine
- Alou, Maryam Tidjani
- Goubet, Anne-Gaëlle
- Lemaitre, Fabien
- Ferrere, Gladys
- Derosa, Lisa
- Duong, Connie P. M.
- Messaoudene, Meriem
- Gagné, Andréanne
- Joubert, Philippe
- De Sordi, Luisa
- Debarbieux, Laurent
- Simon, Sylvain
- Scarlata, Clara-Maria
- Ayyoub, Maha
- Palermo, Belinda
- Facciolo, Francesco
- Boidot, Romain
- Wheeler, Richard
- Boneca, Ivo Gomperts
- Sztupinszki, Zsofia
- Papp, Krisztian
- Csabai, Istvan
- Pasolli, Edoardo
- Segata, Nicola
- Lopez-Otin, Carlos
- Szallasi, Zoltan
- Andre, Fabrice
- Iebba, Valerio
- Quiniou, Valentin
- Klatzmann, David
- Khelaifia, Saber
- Raoult, Didier
- Albiges, Laurence
- Escudier, Bernard
- Eggermont, Alexander
- Nistico, Paola
- Ghiringhelli, François
- Routy, Bertrand
- Labarrière, Nathalie
- Cattoir, Vincent
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2020-08-21
- Volume
- 369
- Issue
- 6506
- Pages
- 936-942
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3081393016
- Cited by
- 396
- References
- 53
- Citations by year
- 2026: 47 · 2025: 77 · 2024: 59 · 2023: 80 · 2022: 61 · 2021: 62 · 2020: 9
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- green
- inserm.hal.science
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-19-CE15-0029, ANR-16-RHUS-0008)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Keywords
- bacteriophages, Enterococcus, cross-reactivity, molecular mimicry, tumor antigens, T cell response, gut microbiota, cancer immunotherapy, anti-PD-1 therapy, chemotherapy, microbial peptides, immune checkpoint inhibitors
- MeSH terms
- Gastrointestinal Microbiome, Enterococcus hirae, Animals, Antibodies, Monoclonal, Epitopes, Antigens, Neoplasm, Bacteriophages, Cross Reactions, Cyclophosphamide, Feces, H-2 Antigens, Humans, Immunotherapy, Neoplasms, Histocompatibility Antigens Class I, Viral Tail Proteins, CD8-Positive T-Lymphocytes, Antineoplastic Agents, Alkylating, Mice, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.